Citation Impact

Citing Papers

Identification of a Domain That Mediates Association of Platelet-activating Factor Acetylhydrolase with High Density Lipoprotein
2008
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
Lp-PLA2- a novel risk factor for high-risk coronary and carotid artery disease
2010
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Evidence that acidic fibroblast growth factor promotes maturation of rat satellite-cell-derived myotubes in vitro
1999
PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases
2004
The safety of statins in clinical practice
2007
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Fibroblast growth factor-2
2000
Apoptosis in the vasculature: mechanisms and functional importance
2000
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis
2009
The roles of Fgf4 and Fgf8 in limb bud initiation and outgrowth
2004 StandoutNobel
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors
2003
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
2002 StandoutNobel
Rosuvastatin for the Treatment of Hypercholesterolemia
2005
Inflammation and insulin resistance
2006 Standout
Inflammatory bio‐markers and cardiovascular risk prediction
2002
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Recent advances in the molecular genetics of primary gliomas
2003
Apop-1, a Novel Protein Inducing Cyclophilin D-dependent but Bax/Bak-related Channel-independent Apoptosis
2006 StandoutNobel
FGF-2: Apical Ectodermal Ridge Growth Signal for Chick Limb Development
1994 Science
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
1995 Standout
Temporal expression of growth factor genes during myogenesis of satellite cells derived from the biceps femoris and pectoralis major muscles of the chicken
2000
The Accelerating Effect of Histamine on the Cutaneous Wound-Healing Process Through the Action of Basic Fibroblast Growth Factor
2006
Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway.
1998
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target
2009
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Hedgehog signaling in animal development: paradigms and principles
2001 Standout
Sonic hedgehog and Fgf-4 act through a signaling cascade and feedback loop to integrate growth and patterning of the developing limb bud
1994 Standout
Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention
2008
FGF Receptor Availability Regulates Skeletal Myogenesis
1999
Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
2018 Standout
Gene Transfer In Vivo with DNA–Liposome Complexes: Lack of Autoimmunity and Gonadal Localization
1992
Vascular Apoptosis and Involution in Gliomas Precede Neovascularization: A Novel Concept for Glioma Growth and Angiogenesis
2000
Dorsalizing signal Wnt-7a required for normal polarity of D–V and A–P axes of mouse limb
1995 StandoutNature
Fibroblast Growth Factors as Multifunctional Signaling Factors
1998
Redox signaling in vascular angiogenesis1,2 1Guest Editor: Toshikazu Yoshikawa 2This article is part of a series of reviews on “Vascular Dysfunction and Free Radicals.” The full list of papers may be found on the homepage of the journal.
2002
Inflammation in Atherosclerosis
2009 Standout
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients
2006
Absence of radius and ulna in mice lacking hoxa-11 andhoxd-11
1995 StandoutNatureNobel
Atherosclerosis
2001 Standout
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
1995 Standout
The role of fibroblast growth factors and their receptors in prostate cancer
2004
Angiogenesis as a therapeutic target
2005 StandoutNature
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture
1999
Molecular neuro-oncology and development of targeted therapeutic strategies for brain tumors. Part 2: PI3K/Akt/PTEN, mTOR, SHH/PTCH and angiogenesis
2004
Physiology and Pathophysiology of Carnosine
2013 Standout
Cell Biology of the Glomerular Podocyte
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Apoptosis During Cardiovascular Development
2000
Arterial Stiffness and Cardiovascular Events
2010 Standout
Normal limb development in conditional mutants of Fgf4
2000 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Control of inositol 1,4,5-trisphosphate-induced Ca2+ release by cytosolic Ca2+
1995 Standout
Global gene expression of cells attached to a tissue engineering scaffold
2004 StandoutNobel
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Gene Regulatory Networks and the Evolution of Animal Body Plans
2006 StandoutScience
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Apoptosis
1999
Lipoprotein-Associated Phospholipase A 2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
2004
Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
2010
Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.
2000
Mechanisms of Estrogen Action
2001 Standout
Lipoprotein-Associated Phospholipase A 2 , High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
2004
Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic Stroke
2005
Lipoprotein-Associated Phospholipase A2 Predicts 5-Year Cardiac Mortality Independently of Established Risk Factors and Adds Prognostic Information in Patients with Low and Medium High-Sensitivity C-Reactive Protein (The Ludwigshafen Risk and Cardiovascular Health Study)
2007
Differentially expressed fibroblast growth factors regulate skeletal muscle development through autocrine and paracrine mechanisms.
1996
The Val279Phe Variant of the Lipoprotein-Associated Phospholipase A2 Gene Is Associated with Catalytic Activities and Cardiovascular Disease in Korean Men
2006
A systematic review and economic evaluation of statins for the prevention of coronary events
2007
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Expression of hypoxia-inducible factor 1? in brain tumors
2000 StandoutNobel
Biomarkers of Cardiovascular Disease
2006
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Flow-Dependent Remodeling in the Carotid Artery of Fibroblast Growth Factor-2 Knockout Mice
2002

Works of Jonathan C. Fox being referenced

Autocrine Signaling through Ras Regulates Cell Survival Activity in Human Glioma Cells: Potential Cross-Talk between Ras and the Phosphatidylinositol 3-Kinase-Akt Pathway
2002
Vitreous-induced Modulation of Integrins in Retinal Pigment Epithelial Cells: Effects of Fibroblast Growth Factor-2
2001
Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme
2004
Auto and transactivation of FGF expression: Potential mechanism for regulation of myogenic differentiation
1993
A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women
2001
Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development
1998
Antisense Inhibition of Basic Fibroblast Growth Factor Induces Apoptosis in Vascular Smooth Muscle Cells
1996
Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model
1998
Cardiovascular Gene Therapy: Current Concepts
1996
Should rosuvastatin be withdrawn from the market?
2004
Angiogenic Gene Therapy
1996
Myogenic differentiation triggered by antisense acidic fibroblast growth factor RNA.
1994
Myogenic Differentiation Triggered by Antisense Acidic Fibroblast Growth Factor RNA
1994
Rankless by CCL
2026